Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018
FDA approved orphan drugs with non-orphan indications 1983-2018
This statistic depicts the percentage of FDA-approved orphan drugs with and without additional non-orphan indications between 1983 and 2018. According to the data, in 2017, 14 percent of approved orphan drugs also had additional non-orphan indications.
Percentage of FDA-approved orphan drugs with additional non-orphan indications between 1983 and 2018
Orphan drugs with non-orphan indicationsOrphan drugs with only orphan indications
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

FDA approved orphan drugs with non-orphan indications 1983-2018
This statistic depicts the percentage of FDA-approved orphan drugs with and without additional non-orphan indications between 1983 and 2018. According to the data, in 2017, 14 percent of approved orphan drugs also had additional non-orphan indications.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Orphan drugs
Orphan drugs

All Information
in one Presentation

Orphan drugs

Everything On "Orphan drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Orphan drugs"
  • Market overview
  • Companies
  • Products
The most important statistics
  • Research and development
  • Rare diseases
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.